Skip to main content

Table 2 The clinical characteristics of the replicate cohort MS patients at the end of the study categorized by rs2304166 genotypes

From: GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients

Rs2304166 genotype (N = 86)

Pre-NTZ treatment

Post 2-year NTZ treatment

EDSS [Median (IQRa)]

EDSS [Median (IQR)]

New CNS lesion (n)

Relapse (n)

GG

3.5 (2.5–4.5)

3 (2–4.75)

0

0

GC

2 (2.5–4.25)

2 (1.5–4.25)

0

0

CC

3.5 (2–5.87)

5.25 (2–6.5)

2

2

  1. aIQR Interquartile range